Page last updated: 2024-09-03

ym 529 and Ewing Sarcoma

ym 529 has been researched along with Ewing Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kubo, T; Matsuo, T; Ochi, M; Sakai, A; Shimose, S	1

Other Studies

1 other study(ies) available for ym 529 and Ewing Sarcoma

Article	Year
Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells. Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Doxorubicin; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Proteins; Humans; Imidazoles; Indicators and Reagents; Mice; Mice, Nude; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Protein Prenylation; Sarcoma, Ewing; Signal Transduction; Xenograft Model Antitumor Assays	2008

Article

Year

Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells.

Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:1

Topics: Animals; Antibiotics, Antineoplastic; Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Doxorubicin; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Proteins; Humans; Imidazoles; Indicators and Reagents; Mice; Mice, Nude; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Protein Prenylation; Sarcoma, Ewing; Signal Transduction; Xenograft Model Antitumor Assays

2008